Quest Diagnostics to Speak at the UBS 2022 Global Healthcare Conference

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) will present at the UBS 2022 Global Healthcare Conference on May 24, 2022, at 3:30 p.m. ET. CEO Steve Rusckowski and CEO-elect Jim Davis will discuss the company's vision and capital strategies. The event will be available via live webcast on the company's investor relations page and archived for later viewing until June 23, 2022. Quest Diagnostics is a leader in diagnostic information services, supporting health improvements for a significant portion of the U.S. population.

SECAUCUS, N.J., May 11, 2022 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS 2022 Global Healthcare Conference. Steve Rusckowski, Chairman, CEO and President and Jim Davis, CEO-elect, will discuss the company's vision, goals, and capital deployment strategies.  The virtual presentation is scheduled for Tuesday, May 24, 2022, at 3:30 p.m. Eastern Time.

The presentation and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com.  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until June 23, 2022.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.  www.QuestDiagnostics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-ubs-2022-global-healthcare-conference-301545341.html

SOURCE Quest Diagnostics

FAQ

When is Quest Diagnostics speaking at the UBS 2022 Global Healthcare Conference?

Quest Diagnostics is scheduled to speak on May 24, 2022, at 3:30 p.m. ET.

Who from Quest Diagnostics will present at the UBS conference?

Steve Rusckowski, Chairman and CEO, and Jim Davis, CEO-elect, will present.

How can I watch the Quest Diagnostics presentation at the UBS conference?

The presentation will be available via live webcast on the Quest Diagnostics investor relations page.

Until when will the Quest Diagnostics conference presentation be available to view?

The archived presentation will be available until June 23, 2022.

What are the main topics Quest Diagnostics will discuss at the UBS conference?

They will discuss the company's vision, goals, and capital deployment strategies.